AGILE 3+ Score for the diagnosis of advanced fibrosis and for predicting liver-related events in NAFLD.

Grazia Pennisi,Marco Enea,Alessandra Pandolfo,Ciro Celsa,Michela Antonucci,Carlo Ciccioli,Giuseppe Infantino,Claudia La Mantia,Stefanie Parisi,Adele Tulone,Vito Di Marco,Antonio Craxì,Calogero Cammà,Salvatore Petta

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association（2022）

引用 23|浏览8

暂无评分

摘要

Depending on resource availability, clinical setting, and the risk scenarios AGILE 3+ is an accurate and valid alternative to FIB-4 and LSM for the noninvasive assessment of disease severity and prognosis in NAFLD patients.

查看译文

关键词

AGILE 3+,DCA,FIBROSIS,NAFLD,NASH

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要